159 related articles for article (PubMed ID: 26309189)
21. MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene.
Kim J; Geyer FC; Martelotto LG; Ng CK; Lim RS; Selenica P; Li A; Pareja F; Fusco N; Edelweiss M; Kumar R; Gularte-Merida R; Forbes AN; Khurana E; Mariani O; Badve S; Vincent-Salomon A; Norton L; Reis-Filho JS; Weigelt B
J Pathol; 2018 Feb; 244(2):143-150. PubMed ID: 29149504
[TBL] [Abstract][Full Text] [Related]
22. MYB rearrangement and immunohistochemical expression in adenomyoepithelioma of the breast: a comparison with adenoid cystic carcinoma.
Baraban E; Zhang PJ; Jaffer S; Lubin D; Feldman M; Bleiweiss IJ; Nayak A
Histopathology; 2018 Dec; 73(6):897-903. PubMed ID: 30003572
[TBL] [Abstract][Full Text] [Related]
23. Analysis of clinicopathological characteristics,
Han J; Zhang C; Gu T; Yang X; Hu L; Tian Z; Li J; Zhang C
Oncol Lett; 2019 Mar; 17(3):2915-2922. PubMed ID: 30854068
[TBL] [Abstract][Full Text] [Related]
24. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck.
Persson M; Andrén Y; Mark J; Horlings HM; Persson F; Stenman G
Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18740-4. PubMed ID: 19841262
[TBL] [Abstract][Full Text] [Related]
25. Detection of MYB Alterations and Other Immunohistochemical Markers in Primary Cutaneous Adenoid Cystic Carcinoma.
North JP; McCalmont TH; Fehr A; van Zante A; Stenman G; LeBoit PE
Am J Surg Pathol; 2015 Oct; 39(10):1347-56. PubMed ID: 26076064
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance.
Mitani Y; Li J; Rao PH; Zhao YJ; Bell D; Lippman SM; Weber RS; Caulin C; El-Naggar AK
Clin Cancer Res; 2010 Oct; 16(19):4722-31. PubMed ID: 20702610
[TBL] [Abstract][Full Text] [Related]
27. MYB, MYBL1, MYBL2 and NFIB gene alterations and MYC overexpression in salivary gland adenoid cystic carcinoma.
Fujii K; Murase T; Beppu S; Saida K; Takino H; Masaki A; Ijichi K; Kusafuka K; Iida Y; Onitsuka T; Yatabe Y; Hanai N; Hasegawa Y; Inagaki H
Histopathology; 2017 Nov; 71(5):823-834. PubMed ID: 28594149
[TBL] [Abstract][Full Text] [Related]
28. MYB-NFIB gene fusion in prostatic basal cell carcinoma: clinicopathologic correlates and comparison with basal cell adenoma and florid basal cell hyperplasia.
Magers MJ; Iczkowski KA; Montironi R; Grignon DJ; Zhang S; Williamson SR; Yang X; Wang M; Osunkoya AO; Lopez-Beltran A; Hes O; Eble JN; Cheng L
Mod Pathol; 2019 Nov; 32(11):1666-1674. PubMed ID: 31189999
[TBL] [Abstract][Full Text] [Related]
29. MYB RNA In Situ Hybridization Facilitates Sensitive and Specific Diagnosis of Adenoid Cystic Carcinoma Regardless of Translocation Status.
Rooper LM; Lombardo KA; Oliai BR; Ha PK; Bishop JA
Am J Surg Pathol; 2021 Apr; 45(4):488-497. PubMed ID: 33165092
[TBL] [Abstract][Full Text] [Related]
30. Detecting MYB and MYBL1 fusion genes in tracheobronchial adenoid cystic carcinoma by targeted RNA-sequencing.
Pei J; Flieder DB; Patchefsky A; Talarchek JN; Cooper HS; Testa JR; Wei S
Mod Pathol; 2019 Oct; 32(10):1416-1420. PubMed ID: 31028361
[TBL] [Abstract][Full Text] [Related]
31. Predictors of Outcome in Adenoid Cystic Carcinoma of Salivary Glands: A Clinicopathologic Study With Correlation Between MYB Fusion and Protein Expression.
Xu B; Drill E; Ho A; Ho A; Dunn L; Prieto-Granada CN; Chan T; Ganly I; Ghossein R; Katabi N
Am J Surg Pathol; 2017 Oct; 41(10):1422-1432. PubMed ID: 28719465
[TBL] [Abstract][Full Text] [Related]
32. UM-HACC-2A: MYB-NFIB fusion-positive human adenoid cystic carcinoma cell line.
Warner KA; Oklejas AE; Pearson AT; Zhang Z; Wu W; Divi V; Rodriguez-Ramirez C; Castilho RM; Polverini PJ; Nör JE
Oral Oncol; 2018 Dec; 87():21-28. PubMed ID: 30527239
[TBL] [Abstract][Full Text] [Related]
33. A unifying gene signature for adenoid cystic cancer identifies parallel MYB-dependent and MYB-independent therapeutic targets.
Gao R; Cao C; Zhang M; Lopez MC; Yan Y; Chen Z; Mitani Y; Zhang L; Zajac-Kaye M; Liu B; Wu L; Renne R; Baker HV; El-Naggar A; Kaye FJ
Oncotarget; 2014 Dec; 5(24):12528-42. PubMed ID: 25587024
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus-related carcinoma with adenoid cystic-like features of the sinonasal tract: clinical and morphological characterization of six new cases.
Andreasen S; Bishop JA; Hansen TV; Westra WH; Bilde A; von Buchwald C; Kiss K
Histopathology; 2017 May; 70(6):880-888. PubMed ID: 28035703
[TBL] [Abstract][Full Text] [Related]
35. c-Myb Overexpression in Cytology Smears of Tracheobronchial and Pulmonary Adenoid Cystic Carcinomas.
Vallonthaiel AG; Jain D; Singh V; Kaur K; Madan K; Kumar V; Iyer VK; Sharma MC
Acta Cytol; 2017; 61(1):77-83. PubMed ID: 27974718
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis of Adenoid Cystic Carcinoma with Striking Tubular Hypereosinophilia by MYB and EWSR1 Breakapart Fluorescence In Situ Hybridization.
Yadav U; Mahendru R; Sharma J; Kakkar A
Head Neck Pathol; 2023 Dec; 17(4):940-951. PubMed ID: 38010473
[TBL] [Abstract][Full Text] [Related]
37. Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome.
Mitani Y; Rao PH; Futreal PA; Roberts DB; Stephens PJ; Zhao YJ; Zhang L; Mitani M; Weber RS; Lippman SM; Caulin C; El-Naggar AK
Clin Cancer Res; 2011 Nov; 17(22):7003-14. PubMed ID: 21976542
[TBL] [Abstract][Full Text] [Related]
38. Development and characterization of xenograft model systems for adenoid cystic carcinoma.
Moskaluk CA; Baras AS; Mancuso SA; Fan H; Davidson RJ; Dirks DC; Golden WL; Frierson HF
Lab Invest; 2011 Oct; 91(10):1480-90. PubMed ID: 21709671
[TBL] [Abstract][Full Text] [Related]
39. MYB Translocations in Both Myoepithelial and Ductoglandular Epithelial Cells in Adenoid Cystic Carcinoma: A Histopathologic and Genetic Reappraisal in Six Primary Cutaneous Cases.
Goto K; Kajimoto K; Sugino T; Nakatsuka SI; Yoshida M; Noto M; Kono M; Takai T
Am J Dermatopathol; 2021 Apr; 43(4):278-283. PubMed ID: 32732690
[TBL] [Abstract][Full Text] [Related]
40. A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma.
Ho AL; Dunn L; Sherman EJ; Fury MG; Baxi SS; Chandramohan R; Dogan S; Morris LG; Cullen GD; Haque S; Sima CS; Ni A; Antonescu CR; Katabi N; Pfister DG
Ann Oncol; 2016 Oct; 27(10):1902-8. PubMed ID: 27566443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
